Company profile: CancerIQ
1.1 - Company Overview
Company description
- Provider of a precision prevention platform for community-based providers, delivering cancer risk assessment (genetic, hereditary, lifestyle), patient navigation, personalized care plan management, analytics and revenue tracking, EHR-integrated software that automates documentation and supports genetic testing and counseling, plus virtual counseling and navigation services for high-risk breast cancer programs.
Products and services
- Software & Services: EHR-integrated platform automates documentation, supports genetic testing and counseling, and integrates with EHRs to streamline precision prevention workflows for community-based providers
- Risk Assessment: Genetic-informed module enables healthcare providers to assess patients’ cancer risk using genetic, hereditary, and lifestyle factors within the platform, underpinning proactive prevention in community settings
- Analytics & Revenue Tracking: Analytics-driven component tracks clinical and financial performance of cancer prevention programs, identifying growth opportunities and optimizing program operations and revenue
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CancerIQ
Kareo
HQ: United States
Website
- Description: Provider of cloud-based software that helps independent practices run a successful business and provide better patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kareo company profile →
Contessa Health
HQ: United States
Website
- Description: Provider of Home Recovery Care, a risk-based model that combines all the essential elements of inpatient hospital care in the comfort of patients' homes, utilizing a proprietary health informatics platform to facilitate safe, affordable care; based in Nashville and founded in 2015.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Contessa Health company profile →
Cirdan
HQ: United Kingdom
Website
- Description: Provider of laboratory information systems and informatics and imaging solutions, designing, manufacturing, and supplying ULTRA, a LIMS to enhance and streamline laboratory workflows, and developing imaging sensors for high-performance cameras using X-ray, near-infrared, and visible light, enabling healthcare professionals to speed patient diagnosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cirdan company profile →
ifa systems
HQ: France
Website
- Description: Provider of information technology solutions for eye care specialists worldwide, including electronic medical record software for retina, cataract, refractive, glaucoma and general ophthalmology; a web- and cloud-based ophthalmology information system; practice management software; and a vendor-neutral archive that integrates diverse medical data formats for centralized access and compliance with data protection regulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ifa systems company profile →
TigerConnect
HQ: United States
Website
- Description: Provider of a healthcare collaboration platform that streamlines clinical workflows and systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TigerConnect company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CancerIQ
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CancerIQ
2.2 - Growth funds investing in similar companies to CancerIQ
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CancerIQ
4.2 - Public trading comparable groups for CancerIQ
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →